A methanol extract of banana peel (BPEx, 200 mg/kg, p.o.) significantly suppressed the regrowth of ventral prostates and seminal vesicles induced by testosterone in castrated mice. Further studies in the androgen-responsive LNCaP human prostate cancer cell line showed that BPEx inhibited dose-dependently testosterone-induced cell growth, while the inhibitory activities of BPEx did not appear against dehydrotestosterone-induced cell growth. These results indicate that methanol extract of banana peel can inhibit 5alpha-reductase and might be useful in the treatment of benign prostate hyperplasia.
Enlargement of the prostate, which affects 50% of men aged 60 and 90% of men by age 80, is referred to as benign prostate hyperplasia (BPH). 1) BPH is a slow, progressive enlargement of the fibromuscular and epithelial structures of the prostate gland.
2) Substantial evidence indicates that the androgens testosterone (T) and dihydrotestosterone (DHT) contribute to the production of BPH.
3) The principal serum androgen T is converted by 5alpha-reductase (5aR) to DHT, which is about 5 times more potent than T itself. DHT binds to androgenic receptors (AR) in the prostate, where it initiates DNA synthesis. 4) This action in turn induces protein synthesis and abnormal growth of the prostate. Current clinical evidence indicates that both inhibition of 5aR and inhibition of the binding of DHT to AR improves the symptoms of BPH in human males.
The effective drugs, finasteride as a 5aR inhibitor and flutamide as a binding inhibitor to AR, are utilized clinically in the treatment of BPH. Alternatively, functional foods are used in a dietary approach to preventing BPH in middle-aged men. Natural products such as lipid extracts of saw palmetto berry extract (SPEx) have also been found to reduce the conversion of T to DHT by inhibiting 5aR both in vitro and in vivo. 5) However, few products of natural origin besides SPEx are believed to be effective against enlargement of the prostate. The scientifically-proven food materials are expected to be of benefit for prevention of BPH. In our preliminary study, the suppressive effects of banana peel extract on enlargement of prostate in BPH model mice were found during screening research for anti-androgen activity among natural sources. Thus it might be useful for preventing overgrowth of the prostate and in prevention of BPH as a functional food for people who want to control their quality of life.
The common banana (Musa spp.) is a tropical fruit that grows in the western hemisphere. Primarily viewed as a food source, the banana has a fleshy inside portion surrounded by an outer typically yellow peel. The fleshy inside portion, or pulp, is edible when raw, and the peel is usually discarded. When ripe, bananas have a deep yellow rind with brown spots, and a creamy pulp, which is easily digested. Bananas are rich in carbohydrates and contain relatively large amounts of vitamins A, B and C and the minerals potassium and phosphorus. 6, 7) However, banana peel has not been studied nutritionally and pharmaceutically as a source of bioactive compounds.
In this report, we examined the effects of banana peel extract (BPEx) on androgen-induced enlargement of accessory reproductive organs in castrated mice. To elucidate the mechanisms of action, the effects of BPEx on the androgen-responsive LNCaP human prostate cancer cell line were investigated. The data presented here indicate that BPEx inhibits growth of the prostate and that BPEx has anti-androgenic activity through inhibition of 5aR.
Materials and Methods
Extract preparation. Fresh peel (2.4 kg) of organically-cultivated bananas was cut and extracted with methanol at room temperature for 2 d. The extracts were filtered, concentrated under a vacuum, and freeze-dried. BPEx (56 g) was stored in a refrigerator before assay.
Chemicals. The chemicals used and their sources were as follows: testosterone and dihydrotestosterone from Wako Pure Chemical Industries (Osaka, Japan); flutamide from Sigma-Aldrich Japan (Tokyo); finasteride from LKT Labs. (St. Paul, MN); and pentobarbital from Dainippon Sumitomo Pharma (Osaka, Japan).
Animals. Std:ddY mice were obtained from SLC (Hamamatsu, Japan). They were maintained at 24 AE 1 C at 50 AE 2% humidity under a 12 h light-dark cycle (lights on from 08:00 to 20:00). Animal studies were performed according to the 2006 guidelines entitled Notification No. 88 of the Ministry of the Environment of Japan.
Evaluation of growth-suppressive effects of mice prostates and seminal vesicles. Assay of growth suppression in castrated mouse prostates and seminal vesicles was performed based on the OECD protocol.
8) The testes of ddY mice were removed at 7 weeks of age under anesthesia by intraperitoneal injection of pentobarbital (50 mg/ml/kg). After 1 d, testosterone propionate at (TP) 2 mg/kg or DHT 6 mg/kg was y To whom correspondence should be addressed. Fax: +81-3-5463-0417; E-mail: tskoyama@kaiyodai.ac.jp Biosci. Biotechnol. Biochem., 73 (9), 1911-1914, 2009 injected intraperitoneally (i.p.) into the mice once daily for 10 d. Enlargement of the reproductive organs in the mice was demonstrated dose-dependently due to testosterone propionate in our preliminary studies. To evaluate the effects on reproductive organs, each of various doses of BPEx, finasteride (FI, 2 mg/kg) and flutamide (FL, 10 mg/kg) was suspended in 1% ethanol and orally administered to the BPH model mice once daily. After 10 d, the mice were weighed, and sacrificed by cervical dislocation. The lengths of the short and long axes of the prostates were then measured with vernier calipers, and the seminal vesicles were removed and weighed. In particular, the weights of the seminal vesicles were sensitive to androgenic effects in our mice model.
Cell culture and growth studies of human prostate cancer cells. The LNCaP human prostate cancer cell line is a well-established androgendependent cell line.
9) AR-positive human prostate cancer LNCaP cells were obtained from the Riken BRC Cell Bank (Tsukuba, Japan). The cells were plated onto a 96-well plate at a density of 2 Â 10 5 /well and supplemented with 10% charcoal stripped fetal bovine serum (CSFBS) obtained from Invitrogen Japan (Tokyo). Twenty-four h later, the cells were treated with either vehicle control or androgens (T or DHT) in the presence and the absence of each concentration of BPEx for another 3 d. BPEx was dissolved in ethanol and added to the cells after further dilution so that the final volume of ethanol was 1% or less. After culture, cell proliferation was determined to measure cell viability by 3-[4,5-dimethyl thiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay.
10) The cells were treated with 1 mg/ml of MTT for 2 h, and precipitated dye was dissolved into dimethylsulfoxide. The absorbance of each well was measured at 570 nm.
Statistical analysis. Data were analyzed statistically by Student's t-test to determine significant differences in the data among the groups. The p values less than 0.05 were considered significant. The values were expressed as mean AE S.E.
Results

Effects of BPEx on growth of mouse prostates and seminal vesicles
The effects of BPEx on the growth of mouse prostates and seminal vesicles were studied as compared with those of flutamide and finasteride in the BPH model mice for 10 d. As shown in Fig. 1 , the short (A) and long (B) axes of the ventral prostates and the weights of the seminal vesicles (C) were severely reduced, and when TP (2 mg/kg i.p.) was injected, significant growth of prostates and seminal vesicles was induced. BPEx (200 mg/kg) produced a reduction in prostate weight. Finasteride (2 mg/kg) and flutamide (10 mg/kg), wellknown anti-androgens, showed larger reductions in prostate weight. Similar results were observed with regard to seminal vesicle weights.
When DHT (6 mg/kg, i.p.) was injected in place of T, significant growth of the prostate and seminal vesicles was induced. BPEx did not inhibit these effects of DHT (Fig. 2) .
Dose-dependency of effects of BPEx on mouse prostates and seminal vesicles
The inhibitory effects of BPEx on the growth of mouse prostates and seminal vesicles were estimated after 10 d of administration (Fig. 3) . BPEx dose-dependently reduced the prostate size and the weights of seminal vesicles, and showed almost maximal effect at 200 mg/kg. 
Discussion
We studied the in vivo potency of BPEx in immature castrated mice. First, when we evaluated dose-depend- ency, BPEx dose-dependently reduced the prostate size and weight of seminal vesicles. In a comparison of BPEx with extract of the flesh of a banana (edible part), the latter had no effect at 200 mg/kg (data not shown). The sizes of the ventral prostate and seminal vesicle of castrated mice were greatly reduced by BPEx, and injection of TP and DHT restored growth to a large extent. These results indicate that the growth of these organs is androgen-dependent.
11) BPEx inhibited TPinduced growth of prostates and seminal vesicles in castrated mice, although it was less potent than finasteride at the same doses. While BPEx inhibited the action of TP, it did not inhibit DHT-induced organ growth. Similar results were found with finasteride, while flutamide reduced the sizes of these organs. In addition, BPEx inhibited cell proliferation in the presence of T, but not in the presence of DHT. These results suggest that BPEx suppressed the growth of prostates and seminal vesicles by inhibiting the conversion of T to DHT, rather than by blocking the binding of androgen and its receptor. BPEx may have reduced prostate size and seminal vesicle weight by inhibiting 5aR.
In further study, we found that treatment of LNCaP cells with BPEx inhibited T-induced cell proliferation. The inhibition of this effect of T might have be due, at least in part, to inhibition of 5aR or to antagonism of androgen binding to the AR. 12) Since 25 mg/ml of BPEx inhibited 5aR activity by about 30%, we expected to find that this dose would inhibit T action. Similar results have been found with finasteride, a well-known inhibitor of 5aR, 13, 14) at doses above 25 mg/ml. Similar results were also found with flutamide, an antagonist of androgen binding to the AR. 15, 16) On the other hand, treatment of LNCaP cells with BPEx in the presence of DHT did not result in a dose-dependent inhibition of cell growth. These results suggest that inhibition of cell growth in the presence of BPEx was not the result of a cell cytotoxic effect, but rather was due to an antiandrogen effect, such as inhibition of 5aR.
According to a previous report describing discrimination between cytotoxic and cytostatic effects of integrants on LNCaP cells, 17) cytotoxic effects are detectable as a decrease in MTT conversion to a level below that of the starting cells. In our experiment, growth of androgen-induced LNCaP cells was suppressed without decreasing from the starting level in the presence of BPEx during the experimental period. Therefore, a cytostatical effect was estimated for suppression of BPEx on LNCaP cell growth. However, since no index markers related to apoptotic signaling were measured in our experiments, the possibility of a non-cytostatical effect should be considered and confirmed in further detailed investigation.
There are generally two ways to suppress prostate regrowth in animal experiments: by inhibiting 5aR activity, and through the use of an androgen receptor antagonist. 18) An androgen antagonist can suppress DHT-induced prostate and seminal vesicle regrowth. 19) Therefore, blocking DHT from binding to androgen receptors in the prostate and seminal vesicle is considered to be a possible mechanism of action (other than 5aR inhibition). 20) To examine this possibility, the effects of BPEx on prostate growth induced by DHT were investigated. If the suppression of prostate growth is caused only by inhibition of 5aR, DHT-induced prostatic regrowth should not be suppressed. Ten d after castration, the weights of mouse prostates were markedly reduced, and prostate size was restored by i.p. injections of TP or DHT. BPEx had no effect on the sizes of the prostate and seminal vesicle of castrated mice that received DHT, whereas flutamide, an androgen receptor antagonist, significantly reduced prostate weight (Fig. 3) . In our study, blood levels of testosterone and samples were not measured, but in vivo and in vitro experiments gave mutually correlated results with regard with their mechanism of action. These results suggest that BPEx inhibited prostate growth by inhibiting 5aR activity rather than by exerting a direct effect on the androgen receptor, although the detailed mechanism including bioavailability remains unclear.
Active compounds showing anti-androgen activity in BPEx are of scientific interest. Recently, there are research reports on components of the banana peel: dietary fiber and pectin, 21) and phytosterol from unripe pulp and peel 22) have been reported. In particular, phytosterols are able to be the active principle in BPEx, due to their anti-androgen activity based on structural similarity. As the extracts from immature peel (green) or edible part without peel of banana did not show antiandrogenic effects in mice (unpublished data), these components could be not simply the active principle in BPEx. Investigation to elucidate the active components in banana peel is in progress.
In this study, we found that BPEx can have antiandrogenic activities through in vitro 5aR inhibitory activity and in vivo growth suppression of prostates and seminal vesicles from castrated mice. For several years, SPEx has been used as a popular phytotherapeutic agent in the treatment of BPH, but its active component and mechanism of action have not been fully elucidated. 23) Banana peel is usually considered useless and is discarded, but the anti-androgenic activity of BPEx might be useful in the treatment of BPH patients. Since the clinical implications of this activity are currently unknown, further research is needed before BPEx can be used in the treatment of BPH. LNCaP cells were incubated with various concentrations of BPEx (shaded column), finasteride (an inhibitor of 5aR, slanted column) or flutamide (an inhibitor of androgen receptor, closed column) in the presence of testosterone (T, 10 mg/ml) (A) and of dihydrotestosterone (DHT, 10 mg/ml) (B) for 24 h. Then cell proliferation was determined to measure cell viability by the 3-[4,5-dimethyl thiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay as described in ''Materials and Methods.'' Each value represents the mean AE S.E., n ¼ 3, Ã , p < 0:05; ÃÃ , p < 0:01; ÃÃÃ , p < 0:005 vs. control (T-or DHT-treated without samples).
